Glaucoma Adherence Study, Spain
NCT00680329 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55
Last updated 2012-05-31
Summary
The purpose of this study is to evaluate adherence to DuoTrav® when reinforced by the use of the Travalert™ Dosing Aid.
Conditions
- Ocular Hypertension
- Primary Open Angle Glaucoma
Interventions
- DRUG
-
Travoprost 0.004%/timolol 0.05% fixed combination eye drops (DuoTrav)
One drop in study eye(s) once daily in the evening for four months
- DEVICE
-
Travalert Dosing Aid
Approved device used with DuoTrav and intended to provide an objective system for quantifying dosing and improving patient adherence
Sponsors & Collaborators
-
Alcon Research
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-05-31
- Primary Completion
- 2009-07-31
- Completion
- 2009-07-31
Countries
- Spain
Study Locations
More Related Trials
-
A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00311389 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure
NCT02003391 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00672997 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Changing to DuoTrav From Prior Therapy
NCT01230736 ·Status: COMPLETED ·Phase: PHASE4
-
An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance
NCT00329095 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Travoprost/Timolol BAC-free
NCT00760539 ·Status: COMPLETED ·Phase: PHASE3
-
Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
NCT00759239 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00333125 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Changing to DUOTRAV® From Prior Therapy
NCT01327599 ·Status: COMPLETED ·Phase: PHASE4
-
Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav
NCT00519753 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy
NCT01514721 ·Status: TERMINATED ·Phase: PHASE4
-
Adherence With Fixed Versus Unfixed Glaucoma Therapy
NCT01281020 ·Status: COMPLETED
-
Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%
NCT00440011 ·Status: COMPLETED ·Phase: PHASE4
-
Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia
NCT01696383 ·Status: WITHDRAWN ·Phase: PHASE4
-
24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG
NCT00757835 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
NCT00051142 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma
NCT00051181 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Glaucoma or Ocular Hypertension in Patients Within the United States
NCT00800267 ·Status: COMPLETED ·Phase: PHASE3
-
DuoTrav® Eye Drops As Replacement Therapy Program
NCT00828906 ·Status: COMPLETED ·Phase: PHASE4
-
An Evaluation of the Ability to Train Established Glaucoma Patients Who Have Difficulty in Drop Instillation
NCT01719809 ·Status: TERMINATED
-
IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00527501 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study Comparing Two Models of a Travoprost Intraocular Implant
NCT03868124 ·Status: COMPLETED ·Phase: PHASE3
-
Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00872651 ·Status: COMPLETED ·Phase: PHASE3
-
A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma
NCT00887029 ·Status: COMPLETED ·Phase: PHASE4
-
Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension
NCT00763061 ·Status: COMPLETED ·Phase: PHASE4